RxDoctor Payments Data

Amanda Vo

Urology · Chicago, ILNPI 1417346164

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,388 of the $32,501 with a category attached, or 87.3%. Boston Scientific accounts for 95.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $15,369, more than ten times the $103 reported in 2020. Among urology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,501in general payments, 2019–2025

Across 48 payments — averaging $677.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$31K
  • Medtronic$1K
  • AbbVie$148
  • Travere Therapeutics, Inc.$116
  • Valencia Technologies Corporation$65
  • Richard Wolf Medical Instruments Corp.$49
  • plus $40 from 1 others
$26,881in research payments, 2019–2025

Across 10 payments — averaging $2688.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$27K

What the payments were for

  • Consulting fees$1,0653%
  • Speaking & faculty fees$28,38887%
  • Travel & lodging$1,2894%
  • Food & beverage$1,7605%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,501 in reported general payments places this provider in the 90th percentile of 550 urology providers in Illinois.

See all urology providers in Illinois

Medicare billing

Part B allowed, 2024
$304,526
Medicare patients
589
Services billed
11,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron118$121,325
GemtesaVibegron47$60,284
Mirabegron ErMirabegron23$18,977
Tamsulosin Hcl208$4,487
Estradiol45$3,265
Potassium Citrate ErPotassium Citrate21$2,229
Tadalafil15$1,083
Alfuzosin Hcl ErAlfuzosin Hcl29$935
Finasteride57$914
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst126$403
Cephalexin57$263
Ciprofloxacin Hcl66$126
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim34$107
Amoxicillin19$65

Paid to pharmacies, not to this prescriber.

Other urology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →